HU177419B
(en)
*
|
1978-07-13 |
1981-10-28 |
Chinoin Gyogyszer Es Vegyeszet |
Process for preparing threedimensional,retentive polymers consisting of cyclodextrin and polyvinylalcohol units,capable of forming inclusion complexes in the form of bead,fibre or mainly block
|
EP0013688B1
(en)
*
|
1978-12-15 |
1984-02-01 |
Kyoshin Co., Ltd. |
A perfumed synthetic resin product and a method of producing said product
|
JPS609524B2
(ja)
*
|
1979-06-01 |
1985-03-11 |
理化学研究所 |
シクロデキストリンの回収法
|
HU184066B
(en)
*
|
1979-12-28 |
1984-06-28 |
Chinoin Gyogyszer Es Vegyeszet |
Plant growth regulating substance and process for preparing such compound
|
HU181733B
(en)
*
|
1980-08-07 |
1983-11-28 |
Chinoin Gyogyszer Es Vegyeszet |
Process for preparing sorbents containing cyclodextrin on cellulose base
|
JPS57130914A
(en)
*
|
1981-02-04 |
1982-08-13 |
Agency Of Ind Science & Technol |
Prolongation of activity retention
|
HU189534B
(en)
*
|
1981-09-09 |
1986-07-28 |
Chinoin Rt.,Hu |
Process for producing new tablets containing cyclodextrin polymer as desintegrator
|
US4448789A
(en)
*
|
1982-08-27 |
1984-05-15 |
Warner-Lambert Company |
Enhanced flavor-releasing agent
|
HU191101B
(en)
*
|
1983-02-14 |
1987-01-28 |
Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu |
Process for preparing water-soluble cyclodextrin polymers substituted with ionic groups
|
JPS6081166A
(ja)
*
|
1983-10-11 |
1985-05-09 |
Fujisawa Pharmaceut Co Ltd |
2−ニトロオキシメチル−6−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法
|
JPS60202115A
(ja)
*
|
1984-03-27 |
1985-10-12 |
Ichiro Shibauchi |
エポキシ樹脂用硬化剤
|
US4596795A
(en)
*
|
1984-04-25 |
1986-06-24 |
The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services |
Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
|
US4727064A
(en)
*
|
1984-04-25 |
1988-02-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Pharmaceutical preparations containing cyclodextrin derivatives
|
JPS61152765A
(ja)
*
|
1984-12-27 |
1986-07-11 |
Nippon Ekishiyou Kk |
シクロデキストリン類で包接された化合物を含有した合成樹脂製品及びその製造方法
|
US4769474A
(en)
*
|
1985-04-10 |
1988-09-06 |
Mitsui Toatsu Chemicals, Inc. |
Process for purifying tryptophane
|
SE452469B
(sv)
*
|
1986-06-18 |
1987-11-30 |
Pharmacia Ab |
Material bestaende av en tverbunden karboxylgrupphaltig polysackarid och forfarande vid framstellning av detsamma
|
US4897472A
(en)
*
|
1986-11-19 |
1990-01-30 |
Oy Alko Ab |
Process for isolation and purification of cyclodextrins
|
US4808232A
(en)
*
|
1986-12-08 |
1989-02-28 |
American Maize-Products Company |
Separation and purification of cyclodextrins
|
US5273820A
(en)
*
|
1986-12-08 |
1993-12-28 |
American Maize-Products Company |
Separation and purification of cyclodextrins
|
US4898921A
(en)
*
|
1987-06-03 |
1990-02-06 |
Montclair State College |
Conducting polymer films, method of manufacture and applications therefor
|
US5637575A
(en)
*
|
1988-01-19 |
1997-06-10 |
The Trustees Of The University Of Pennsylvania |
Methods of inhibiting restenosis
|
US5760015A
(en)
*
|
1988-01-19 |
1998-06-02 |
The Trustees Of The University Of Pennsylvania |
Cyclodextrin compounds and methods of making and use thereof
|
US5658894A
(en)
*
|
1989-04-23 |
1997-08-19 |
The Trustees Of The University Of Pennsylvania |
Compositions for inhibiting restenosis
|
JPH0269540A
(ja)
*
|
1988-09-05 |
1990-03-08 |
Chisso Corp |
結晶性ポリオレフイン組成物
|
US5441944A
(en)
*
|
1989-04-23 |
1995-08-15 |
The Trustees Of The University Of Pennsylvania |
Substituted cyclodextrin sulfates and their uses as growth modulating agents
|
US5075432A
(en)
*
|
1989-08-11 |
1991-12-24 |
Edward Vanzo |
Spherical cyclodextrin polymer beads
|
IT1255981B
(it)
*
|
1991-04-30 |
1995-11-17 |
Ministero Dell Uni E Della |
Composizione adesiva a piu' componenti
|
US5446030A
(en)
*
|
1991-09-19 |
1995-08-29 |
Weisz; Paul B. |
Prevention of hemolysis
|
BR9405858A
(pt)
*
|
1993-03-31 |
1995-12-12 |
Univ Pennsylvania |
Processos de afetar o crescimento de tecido vivo em mamiferos compostos e composiçÕes para os mesmos
|
US5492947A
(en)
*
|
1994-06-23 |
1996-02-20 |
Aspen Research Corporation |
Barrier material comprising a thermoplastic and a compatible cyclodextrin derivative
|
US6048736A
(en)
*
|
1998-04-29 |
2000-04-11 |
Kosak; Kenneth M. |
Cyclodextrin polymers for carrying and releasing drugs
|
AU2003294258B2
(en)
*
|
2003-01-16 |
2009-05-28 |
Cornell Research Foundation, Inc. |
Partially biodegradable temperature and pH sensitive hydrogel
|
ES2905724T3
(es)
|
2003-06-13 |
2022-04-11 |
Alnylam Europe Ag |
Acido ribonucleico bicatenario con elevada eficacia en un organismo
|
ES2515092T3
(es)
|
2003-12-11 |
2014-10-29 |
Sunovion Pharmaceuticals Inc. |
Combinación de un sedante y un modulador neurotransmisor y métodos de mejorar la calidad del sueño y de tratar la depresión
|
EP2610234A1
(en)
|
2004-02-24 |
2013-07-03 |
The General Hospital Corporation |
Catalytic radiofluorination
|
EP3034510A1
(en)
|
2004-04-30 |
2016-06-22 |
Alnylam Pharmaceuticals Inc. |
Oligonucleotides comprising a c5-modified pyrimidine
|
BRPI0511070A
(pt)
|
2004-06-17 |
2007-11-27 |
Infinity Pharmaceuticals Inc |
compostos e processos para inibição da interação de proteìnas bcl com parceiros de ligação
|
CN101287468A
(zh)
*
|
2005-02-18 |
2008-10-15 |
表面线段公司 |
制备包含官能性残基或基团的药动学改善的化合物的方法以及包含所述化合物的药用组合物
|
EP1850853A4
(en)
*
|
2005-02-18 |
2011-09-07 |
Surface Logix Inc |
PHARMACOKINETICALLY IMPROVED COMPOUNDS
|
ES2310948B2
(es)
|
2005-02-25 |
2009-09-16 |
Universidade De Santiago De Compostela |
Procedimiento de obtencion de hidrogeles de ciclodextrinas con glicidileteres, las composiciones obtenidas y sus aplicaciones.
|
WO2006124726A2
(en)
*
|
2005-05-12 |
2006-11-23 |
The General Hospital Corporation |
Novel biotinylated compositions
|
KR100791978B1
(ko)
*
|
2005-06-21 |
2008-01-04 |
곽해수 |
콜레스테롤 제거용 베타-싸이클로덱스트린의 가교화 및그의 재생방법
|
EP2054386B1
(en)
|
2006-08-03 |
2014-10-08 |
Trustees Of Tufts College |
Non-flushing niacin analogues, and methods of use thereof
|
KR100785913B1
(ko)
*
|
2006-11-29 |
2007-12-17 |
한국과학기술연구원 |
경화된 β-사이클로덱스트린 중합체 분말과 그의 제조방법
|
WO2009013770A1
(en)
*
|
2007-07-26 |
2009-01-29 |
Humanitas Mirasole S.P.A. |
Derivatised polysaccharide material for the transdermal administration of drugs
|
WO2009032199A1
(en)
*
|
2007-08-31 |
2009-03-12 |
The Board Of Trustees Operating |
Beta-cyclodextrins as nucleating agents for poly(lactic acid)
|
EP2350281B1
(en)
|
2008-10-24 |
2014-05-14 |
Sarepta Therapeutics, Inc. |
Multiple exon skipping compositions for dmd
|
WO2011060320A1
(en)
|
2009-11-13 |
2011-05-19 |
Avi Biopharma, Inc. |
Antisense antiviral compound and method for treating influenza viral infection
|
EP2545173A2
(en)
|
2010-03-12 |
2013-01-16 |
Sarepta Therapeutics, Inc. |
Antisense modulation of nuclear hormone receptors
|
ES2816898T3
(es)
|
2010-05-13 |
2021-04-06 |
Sarepta Therapeutics Inc |
Compuestos que modulan la actividad de señalización de las interleucinas 17 y 23
|
WO2011163612A1
(en)
|
2010-06-24 |
2011-12-29 |
Trustees Of Tufts College |
Niacin mimetics, and methods of use thereof
|
AU2011270726C1
(en)
|
2010-06-24 |
2016-02-18 |
Arisaph Pharmaceuticals, Inc. |
Niacin mimetics, and methods of use thereof
|
US10463687B2
(en)
|
2011-01-20 |
2019-11-05 |
Cornell University |
Treatments for retinal disorders
|
EP2732035A2
(en)
|
2011-07-15 |
2014-05-21 |
Sarepta Therapeutics, Inc. |
Methods and compositions for manipulating translation of protein isoforms from alternative initiation start sites
|
JP6132849B2
(ja)
|
2011-12-08 |
2017-05-31 |
サレプタ セラピューティクス, インコーポレイテッド |
ヒトlmnaを標的とするオリゴヌクレオチド類似体を使用する早老性ラミノパシーを処置するための方法
|
JP2015503516A
(ja)
|
2011-12-23 |
2015-02-02 |
ノバルティス アーゲー |
Bcl2と結合相手の相互作用を阻害するための化合物
|
AU2012355613A1
(en)
|
2011-12-23 |
2014-07-17 |
Novartis Ag |
Compounds for inhibiting the interaction of BCL2 with binding partners
|
JP2015503517A
(ja)
|
2011-12-23 |
2015-02-02 |
ノバルティス アーゲー |
Bcl2と結合相手の相互作用を阻害するための化合物
|
EP2794591A1
(en)
|
2011-12-23 |
2014-10-29 |
Novartis AG |
Compounds for inhibiting the interaction of bcl2 with binding partners
|
EP2794592A1
(en)
|
2011-12-23 |
2014-10-29 |
Novartis AG |
Compounds for inhibiting the interaction of bcl2 with binding partners
|
AP3613A
(en)
|
2012-05-15 |
2016-02-29 |
Novartis Ag |
Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1 abl1abl2 bcr-abl1
|
MX2014013373A
(es)
|
2012-05-15 |
2015-08-14 |
Novartis Ag |
Derivados de benzamida para inhibir la actividad de abl1, abl2 y bcr-abl1.
|
KR20150008406A
(ko)
|
2012-05-15 |
2015-01-22 |
노파르티스 아게 |
Abl1, abl2 및 bcr-abl1의 활성을 억제하기 위한 벤즈아미드 유도체
|
PT2900637T
(pt)
|
2012-05-15 |
2017-11-15 |
Novartis Ag |
Derivados de amida de pirimidina, piridina e pirazina substituídos com tiazole ou imidazole e compostos relacionados como inibidores de abl1, abl2 e bcr-abl1 para tratamento do cancro, infecções virais específicas e disturbios do snc específicos
|
WO2014036427A1
(en)
|
2012-08-31 |
2014-03-06 |
The General Hospital Corporation |
Biotin complexes for treatment and diagnosis of alzheimer's disease
|
FR2999916B1
(fr)
|
2012-12-20 |
2015-01-30 |
Oreal |
Composition permettant la liberation d'agent benefique comprenant un polycondensat de cyclodextrine insoluble dans l'eau et au moins un agent benefique
|
AU2013364158A1
(en)
|
2012-12-20 |
2015-07-09 |
Sarepta Therapeutics, Inc. |
Improved exon skipping compositions for treating muscular dystrophy
|
FR3000080B1
(fr)
|
2012-12-20 |
2015-01-30 |
Oreal |
Polycondensat de cyclodextrine insoluble dans l'eau ; utilisations comme agent de capture
|
HUE039052T2
(hu)
|
2013-02-19 |
2018-12-28 |
Novartis Ag |
Benzotiofénszármazékok és azok készítményei szelektív ösztrogén receptor lebontóként
|
CN110066793A
(zh)
|
2013-03-14 |
2019-07-30 |
萨勒普塔医疗公司 |
用于治疗肌肉萎缩的外显子跳跃组合物
|
BR122020016865B1
(pt)
|
2013-03-14 |
2022-12-27 |
Sarepta Therapeutics, Inc. |
Oligonucleotídeo antisenso, composição farmacêutica compreendendo o mesmo e uso da dita composição para o tratamento de distrofia muscular de duchenne (dmd)
|
CA2906812A1
(en)
|
2013-03-15 |
2014-09-18 |
Sarepta Therapeutics, Inc. |
Improved compositions for treating muscular dystrophy
|
US9227969B2
(en)
|
2013-08-14 |
2016-01-05 |
Novartis Ag |
Compounds and compositions as inhibitors of MEK
|
WO2015022664A1
(en)
|
2013-08-14 |
2015-02-19 |
Novartis Ag |
Compounds and compositions as inhibitors of mek
|
WO2015022663A1
(en)
|
2013-08-14 |
2015-02-19 |
Novartis Ag |
Compounds and compositions as inhibitors of mek
|
WO2015092634A1
(en)
|
2013-12-16 |
2015-06-25 |
Novartis Ag |
1,2,3,4-tetrahydroisoquinoline compounds and compositions as selective estrogen receptor antagonists and degraders
|
JP6473457B2
(ja)
|
2014-01-17 |
2019-02-20 |
ノバルティス アーゲー |
Shp2の活性を阻害するための1−(トリアジン−3−イル/ピリダジン−3−イル)−ピペリジン/ピペラジン誘導体およびその組成物
|
US10093646B2
(en)
|
2014-01-17 |
2018-10-09 |
Novartis Ag |
1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2
|
JO3517B1
(ar)
|
2014-01-17 |
2020-07-05 |
Novartis Ag |
ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2
|
CA2981139A1
(en)
|
2015-04-01 |
2016-10-06 |
International Dioxide, Inc |
Stabilized composition for combined odor control and enhanced dewatering
|
CN112625028A
(zh)
|
2015-06-19 |
2021-04-09 |
诺华股份有限公司 |
用于抑制shp2活性的化合物和组合物
|
EP3310779B1
(en)
|
2015-06-19 |
2019-05-08 |
Novartis AG |
Compounds and compositions for inhibiting the activity of shp2
|
WO2016203405A1
(en)
|
2015-06-19 |
2016-12-22 |
Novartis Ag |
Compounds and compositions for inhibiting the activity of shp2
|
CN108738310A
(zh)
|
2015-09-30 |
2018-11-02 |
萨勒普塔医疗公司 |
用于治疗肌营养不良的方法
|
EA201892467A1
(ru)
|
2016-04-29 |
2019-05-31 |
Сарепта Терапьютикс, Инк. |
Олигонуклеотидные аналоги, нацеленные на lmna человека
|
EA036446B1
(ru)
|
2016-06-14 |
2020-11-11 |
Новартис Аг |
Соединения и композиции для подавления активности shp2
|
MA45618A
(fr)
|
2016-06-30 |
2019-05-08 |
Sarepta Therapeutics Inc |
Sauts d'exons oligomères pour la dystrophie musculaire
|
SG10202100491QA
(en)
|
2016-12-19 |
2021-02-25 |
Sarepta Therapeutics Inc |
Exon skipping oligomer conjugates for muscular dystrophy
|
HUE059843T2
(hu)
|
2016-12-19 |
2023-01-28 |
Sarepta Therapeutics Inc |
Exonátugró oligomerkonjugátumok izomdisztrófiára
|
CN110636866A
(zh)
|
2016-12-19 |
2019-12-31 |
萨勒普塔医疗公司 |
用于肌肉萎缩症的外显子跳跃寡聚体缀合物
|
WO2018195338A1
(en)
|
2017-04-20 |
2018-10-25 |
Atyr Pharma, Inc. |
Compositions and methods for treating lung inflammation
|
EA201991450A1
(ru)
|
2017-09-22 |
2019-12-30 |
Сарепта Терапьютикс, Инк. |
Конъюгаты олигомеров для пропуска экзона при мышечной дистрофии
|
US20200254002A1
(en)
|
2017-09-28 |
2020-08-13 |
Sarepta Therapeutics, Inc. |
Combination therapies for treating muscular dystrophy
|
WO2019067975A1
(en)
|
2017-09-28 |
2019-04-04 |
Sarepta Therapeutics, Inc. |
POLYTHERAPIES FOR TREATING MUSCLE DYSTROPHY
|
JP2020536058A
(ja)
|
2017-09-28 |
2020-12-10 |
サレプタ セラピューティクス, インコーポレイテッド |
筋ジストロフィーを処置するための併用療法
|
US10758629B2
(en)
|
2018-05-29 |
2020-09-01 |
Sarepta Therapeutics, Inc. |
Exon skipping oligomer conjugates for muscular dystrophy
|
EP4219717A3
(en)
|
2018-06-13 |
2023-12-20 |
Sarepta Therapeutics, Inc. |
Exon skipping oligomers for muscular dystrophy
|
CN108435148A
(zh)
*
|
2018-06-21 |
2018-08-24 |
黄益良 |
一种环糊精改性聚丙烯酰胺污水处理剂及其制备方法
|
TW202020153A
(zh)
|
2018-07-27 |
2020-06-01 |
美商薩羅塔治療公司 |
用於肌肉萎縮症之外顯子跳躍寡聚物
|
WO2020123574A1
(en)
|
2018-12-13 |
2020-06-18 |
Sarepta Therapeutics, Inc. |
Exon skipping oligomer conjugates for muscular dystrophy
|
CN113490691A
(zh)
|
2019-01-03 |
2021-10-08 |
劣势者药物有限公司 |
环糊精二聚体、其组合物及其用途
|
CN109663578B
(zh)
*
|
2019-02-22 |
2022-02-25 |
安徽大学 |
一种对刚果红超高吸附能力的混合卤化物(MV)[BiI3Cl2]的制备方法及其产品
|
CN109806849A
(zh)
*
|
2019-03-25 |
2019-05-28 |
东华大学 |
一种环糊精纳米空心小球及其制备方法
|
JP2022526763A
(ja)
|
2019-03-28 |
2022-05-26 |
サレプタ セラピューティクス, インコーポレイテッド |
カシメルセンによる筋ジストロフィーの治療方法
|
EP3955966A1
(en)
|
2019-04-18 |
2022-02-23 |
Sarepta Therapeutics, Inc. |
Compositions for treating muscular dystrophy
|
JP2022536495A
(ja)
|
2019-06-19 |
2022-08-17 |
サレプタ セラピューティクス, インコーポレイテッド |
筋ジストロフィーを治療する方法
|
WO2021101606A1
(en)
*
|
2019-11-18 |
2021-05-27 |
Pmidg, Llc |
Compositions for sunscreen compounds and methods thereof
|
CN113372674B
(zh)
*
|
2021-08-13 |
2021-10-19 |
山东三义集团股份有限公司 |
一种氯化聚乙烯用高速挤出加工改性助剂的制备方法
|
WO2023178230A1
(en)
|
2022-03-17 |
2023-09-21 |
Sarepta Therapeutics, Inc. |
Phosphorodiamidate morpholino oligomer conjugates
|
WO2024073570A1
(en)
|
2022-09-28 |
2024-04-04 |
Altos Labs, Inc. |
Expression of regeneration factors in aged/senescent cells
|